5-Iodo-7-(2-C-methyl-beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine structure
|
Common Name | 5-Iodo-7-(2-C-methyl-beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | ||
---|---|---|---|---|
CAS Number | 847551-49-9 | Molecular Weight | 406.18 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C12H15IN4O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of 5-Iodo-7-(2-C-methyl-beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine4-Amino-5-iodo-7-(2-β-C-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
Name | 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 5-iodo-7-(2-C-methyl-β-D-ribofuranosyl) |
---|---|
Synonym | More Synonyms |
Description | 4-Amino-5-iodo-7-(2-β-C-methyl-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C12H15IN4O4 |
---|---|
Molecular Weight | 406.18 |
Exact Mass | 406.01400 |
PSA | 126.65000 |
LogP | 0.20090 |
5-iodo-7-(2-c-methyl-beta-d-ribofuranosyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine |